<DOC>
	<DOCNO>NCT01532661</DOCNO>
	<brief_summary>The rFVIIa ( Novoseven ) test traumatic hemorrhage efficiency proven yet context . A national register set France identify patient receive rFVIIa . Those patient persistent active bleeding severe trauma despite surgery and/or interventional radiology embolization . The aim present study report first clinical result situation patient treat rFVIIa .</brief_summary>
	<brief_title>National Registry rFVIIa ( Novoseven ) Haemorrhagic Traumatology</brief_title>
	<detailed_description>It consist study prospective cohort 36 center , 3 year , April 1st 2008 . The data patient receive rFVIIa traumatic situation collect . The investigator colligate clinical biological parameter ; analyze treatment receive initial care , intensive care receive rFVIIa , length stay ICU , secondary effect , complication patient outcome . ISS TRISS score calculate predict mortality .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<criteria>people affiliate social security patient admit ISU haemorrhagic trauma patient receive rFVIIa treatment bleed control allergy hypersensitivity rVIIa one component</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>TRAUMA</keyword>
	<keyword>HAEMORRHAGIC</keyword>
	<keyword>rVIIa</keyword>
	<keyword>Complication Trauma hemorrhage</keyword>
	<keyword>bleeding</keyword>
	<keyword>rFVIIa administration hemorrhage trauma</keyword>
</DOC>